论文部分内容阅读
目的:研究奥德金和醒脑静合用治疗急性一氧化碳中毒(ACMP)的疗效及其预防迟发性脑病的作用。方法:将72例ACMP患者,随机分为对照组34例(常规治疗组)和治疗组38例(加用奥德金和醒脑静注射液),观察两组疗效及迟发性脑病的发生率。结果:治疗组和对照组的显效率,有效率,无效率分别为78.95%,13.16%,7.89%和35.29%,44.12%,25.00%。治疗组临床疗效明显高于对照组。迟发性脑病发生率分别为10.53%和41.18%,治疗组明显低于对照组,两组间差异有统计学意义(P<0.05)。结论:奥德金和醒脑静合用可以明显缩短ACMP患者的意识障碍时间,显著提高疗效,减少迟发性脑病的发生率。值得推广。
Objective: To study the efficacy of Oudin and xingnaojing in treating acute carbon monoxide poisoning (ACMP) and the preventive effect of delayed encephalopathy. Methods: Seventy-two patients with ACMP were randomly divided into control group (n = 34) and control group (n = 38), with the treatment of Oddkin and Xingnaojing injection. The curative effect and delayed encephalopathy rate. Results: The effective rate, effective rate and inefficiency of the treatment group and the control group were 78.95%, 13.16%, 7.89% and 35.29%, 44.12% and 25.00% respectively. The clinical efficacy of the treatment group was significantly higher than that of the control group. The incidences of delayed encephalopathy were 10.53% and 41.18% respectively, which were significantly lower in the treatment group than those in the control group. There was significant difference between the two groups (P <0.05). Conclusion: Oudin and Xingnaojing combined can significantly reduce the disturbance of consciousness in ACMP patients, significantly improve the efficacy and reduce the incidence of delayed encephalopathy. Worth promoting.